Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRAST-2: Lipid-lowering Therapy in STEMI/NSTEMI Patients
NCT04347434Phase 4Recruiting
- Sponsor
- Penza State University
- Start
- Feb 2020
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, ezetimibe in myocardial infarction (MI), sponsored by Penza State University. Started Feb 2020; status: recruiting.
02
Drugs
atorvastatinezetimibe
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04347434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347434.